These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26488212)

  • 1. Clinicopathological and genetic differences between low-grade and high-grade colorectal mucinous adenocarcinomas.
    Yoshioka Y; Togashi Y; Chikugo T; Kogita A; Taguri M; Terashima M; Mizukami T; Hayashi H; Sakai K; de Velasco MA; Tomida S; Fujita Y; Tokoro T; Ito A; Okuno K; Nishio K
    Cancer; 2015 Dec; 121(24):4359-68. PubMed ID: 26488212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung.
    Shim HS; Kenudson M; Zheng Z; Liebers M; Cha YJ; Hoang Ho Q; Onozato M; Phi Le L; Heist RS; Iafrate AJ
    J Thorac Oncol; 2015 Aug; 10(8):1156-62. PubMed ID: 26200269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of the BRAF gene in colorectal mucinous carcinoma in association with histological configuration.
    Yoshitake N; Fujii S; Mukawa K; Tominaga K; Fukui H; Ichikawa K; Tomita S; Ono Y; Imai Y; Terano A; Hiraishi H; Fujimori T
    Oncol Rep; 2007 Jan; 17(1):9-15. PubMed ID: 17143472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma.
    Kim H; Kim BH; Lee D; Shin E
    Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and genetic determinants of ovarian metastases from colorectal cancer.
    Ganesh K; Shah RH; Vakiani E; Nash GM; Skottowe HP; Yaeger R; Cercek A; Lincoln A; Tran C; Segal NH; Reidy DL; Varghese A; Epstein AS; Sonoda Y; Chi D; Guillem J; Temple L; Paty P; Hechtman J; Shia J; Weiser M; Aguilar JG; Kemeny N; Berger MF; Saltz L; Stadler ZK
    Cancer; 2017 Apr; 123(7):1134-1143. PubMed ID: 27875625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.
    Tanskanen T; Gylfe AE; Katainen R; Taipale M; Renkonen-Sinisalo L; Mecklin JP; Järvinen H; Tuupanen S; Kilpivaara O; Vahteristo P; Aaltonen LA
    Scand J Gastroenterol; 2013 Jun; 48(6):672-8. PubMed ID: 23544471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous adenocarcinomas: poor prognosis in metastatic colorectal cancer.
    Mekenkamp LJ; Heesterbeek KJ; Koopman M; Tol J; Teerenstra S; Venderbosch S; Punt CJ; Nagtegaal ID
    Eur J Cancer; 2012 Mar; 48(4):501-9. PubMed ID: 22226571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference between proximal and distal microsatellite-unstable sporadic colorectal cancers: analysis of clinicopathological and molecular features and prognoses.
    Kim YH; Min BH; Kim SJ; Choi HK; Kim KM; Chun HK; Lee H; Kim JY; Chang DK; Son HJ; Rhee PL; Rhee JC; Kim JJ
    Ann Surg Oncol; 2010 May; 17(5):1435-41. PubMed ID: 20049642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serrated adenocarcinoma morphology in colorectal mucinous adenocarcinoma is associated with improved patient survival.
    Lee CT; Huang YC; Hung LY; Chow NH; Su PF; Ho CL; Tsai HW; Chen YL; Lin SC; Lin BW; Lin PC; Lee JC
    Oncotarget; 2017 May; 8(21):35165-35175. PubMed ID: 28422723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct Clinicopathological Patterns of Mismatch Repair Status in Colorectal Cancer Stratified by KRAS Mutations.
    Li W; Zhi W; Zou S; Qiu T; Ling Y; Shan L; Shi S; Ying J
    PLoS One; 2015; 10(6):e0128202. PubMed ID: 26042813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal carcinomas with mucinous differentiation are associated with high frequent mutation of KRAS or BRAF mutations, irrespective of quantity of mucinous component.
    Li X; Sun K; Liao X; Gao H; Zhu H; Xu R
    BMC Cancer; 2020 May; 20(1):400. PubMed ID: 32384877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS and NKX2-1 Mutations in Invasive Mucinous Adenocarcinoma of the Lung.
    Hwang DH; Sholl LM; Rojas-Rudilla V; Hall DL; Shivdasani P; Garcia EP; MacConaill LE; Vivero M; Hornick JL; Kuo FC; Lindeman NI; Dong F
    J Thorac Oncol; 2016 Apr; 11(4):496-503. PubMed ID: 26829311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical and mutational analyses of beta-catenin, Ki-ras, and p53 in two subtypes of colorectal mucinous carcinoma.
    Ikeda S; Shimizu Y; Fujimori M; Ishizaki Y; Kurihara T; Ojima Y; Okajima M; Asahara T
    Clin Cancer Res; 2003 Nov; 9(15):5660-5. PubMed ID: 14654549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
    Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
    J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.
    Lee SM; Sung CO
    Sci Rep; 2021 Mar; 11(1):6203. PubMed ID: 33737597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Significance and Molecular Features of Colorectal Mucinous Adenocarcinomas: A Strobe-Compliant Study.
    Wang MJ; Ping J; Li Y; Holmqvist A; Adell G; Arbman G; Zhang H; Zhou ZG; Sun XF
    Medicine (Baltimore); 2015 Dec; 94(51):e2350. PubMed ID: 26705231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous mutational profile and prognosis conferred by TP53 mutations in appendiceal mucinous neoplasms.
    Zhu X; Salhab M; Tomaszewicz K; Meng X; Mathew C; Bathini V; Switzer B; Walter O; Cosar EF; Wang X; Lambert LA; Hutchinson LM
    Hum Pathol; 2019 Mar; 85():260-269. PubMed ID: 30458197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer without high microsatellite instability and chromosomal instability--an alternative genetic pathway to human colorectal cancer.
    Tang R; Changchien CR; Wu MC; Fan CW; Liu KW; Chen JS; Chien HT; Hsieh LL
    Carcinogenesis; 2004 May; 25(5):841-6. PubMed ID: 14729584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.